Evidence map›Paper›PMID 32468902›Full record

ArticleJournal of the American Heart Association2020

Tetrodotoxin-Sensitive Neuronal-Type Na

Mark A Munger, Yusuf Olğar, Megan L Koleske, Heather L Struckman, Jessica Mandrioli, Qing Lou, Ingrid Bonila, Kibum Kim, Roberto Ramos Mondragon, Silvia G Priori and 7 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in Journal of the American Heart Association, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 17 citations in OpenAlex.

  1. Selective activation of tetrodotoxin-sensitive sodium channels by AaH-II drives arrhythmogenic late Na+ current in the heart.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2026
    Article
  2. Small-conductance CaThe Journal of physiology · 2026
    Review
  3. Restoration of mitochondrial CaJournal of molecular and cellular cardiology · 2026
    Article
  4. Article
  5. Selectivity Filter Mutation in NaJACC. Clinical electrophysiology · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Observational
  11. Article
  12. Article
  13. A Possible Role of Tetrodotoxin-Sensitive NaInternational journal of molecular sciences · 2024
    Article
  14. Article
  15. Ion channel trafficking implications in heart failure.Frontiers in cardiovascular medicine · 2024
    Review
  16. Article
  17. Review
  18. Article
  19. Tetrodotoxin-Sensitive Neuronal-Type NaJournal of the American Heart Association · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 7 institutions in 2 countries.

Mark A MungerDepartments of Pharmacotherapy and Internal Medicine University of Utah Health Sciences Center Salt Lake City UT.
Yusuf OlğarDorothy M. Davis Heart and Lung Research Institute College of Medicine The Ohio State University Wexner Medical Center Columbus OH.
Megan L KoleskeDorothy M. Davis Heart and Lung Research Institute College of Medicine The Ohio State University Wexner Medical Center Columbus OH.
Heather L StruckmanDepartment of Biomedical Engineering College of Engineering The Ohio State University Columbus OH.
Jessica MandrioliDepartment of Neuroscience St. Agostino Estense Hospital Azienda Ospedaliero Universitaria di Modena Italy.
Qing LouDorothy M. Davis Heart and Lung Research Institute College of Medicine The Ohio State University Wexner Medical Center Columbus OH.
Ingrid BonilaDorothy M. Davis Heart and Lung Research Institute College of Medicine The Ohio State University Wexner Medical Center Columbus OH.
Kibum KimDepartment of Pharmacotherapy University of Utah Health Sciences Center Salt Lake City UT.
Roberto Ramos MondragonDepartment of Internal Medicine and of Molecular & Integrative Physiology University of Michigan Ann Arbor MI.
Silvia G PrioriMolecular Cardiology Istituti Clinici Scientifici Maugeri IRCCS University of Pavia Italy.
Pompeo VolpeDepartment of Biomedical Sciences University of Padova Italy.
Héctor H ValdiviaDepartment of Internal Medicine and of Molecular & Integrative Physiology University of Michigan Ann Arbor MI.
Joseph BiskupiakDepartment of Pharmacotherapy University of Utah Health Sciences Center Salt Lake City UT.
Cynthia A CarnesDorothy M. Davis Heart and Lung Research Institute College of Medicine The Ohio State University Wexner Medical Center Columbus OH.
Rengasayee VeeraraghavanDepartment of Biomedical Engineering College of Engineering The Ohio State University Columbus OH.
Sándor GyörkeDorothy M. Davis Heart and Lung Research Institute College of Medicine The Ohio State University Wexner Medical Center Columbus OH.
Przemysław B RadwańskiDorothy M. Davis Heart and Lung Research Institute College of Medicine The Ohio State University Wexner Medical Center Columbus OH.
The Ohio State University · USThe Ohio State University Wexner Medical Center · USUniversity of Utah · USUniversity of Michigan–Ann Arbor · USAzienda Unita' Sanitaria Locale Di Modena · ITUniversity of Padua · ITUniversity of Pavia · IT

Funding

CONTROLLED AND UNCONTROLLABLE CALCIUM RELEASE IN HEARTR01HL063043 · NHLBI · TEXAS TECH UNIVERSITY HEALTH SCIS CENTER · PI Sandor Gyorke · 1999 to 2026
$8.6M
Ryanodine Receptor Channels in Heart FailureR01HL074045 · NHLBI · TEXAS TECH UNIVERSITY HEALTH SCIS CENTER · PI GYORKE, SANDOR · 2003 to 2024
$8.2M
Microdomain regulation of Ca2+ release in cardiac physiology and diseaseR00HL127299 · NHLBI · OHIO STATE UNIVERSITY · PI RADWANSKI, PRZEMYSLAW · 2017 to 2019
$740k
Microdomain regulation of Ca2+ release in cardiac physiology and diseaseK99HL127299 · NHLBI · OHIO STATE UNIVERSITY · PI RADWANSKI, PRZEMYSLAW · 2015 to 2016
$233k
NHLBI NIH HHS K99 HL127299NHLBI NIH HHS R00 HL127299NHLBI NIH HHS R01 HL063043NHLBI NIH HHS R01 HL074045
6 · The paper itself

Abstract

Background Atrial fibrillation (AF) is a comorbidity associated with heart failure and catecholaminergic polymorphic ventricular tachycardia. Despite the Ca

Indexed as

AdultAnimalsAnti-Arrhythmia AgentsAtrial FibrillationCalcium SignalingCardiac Pacing, ArtificialCatecholaminesDisease Models, AnimalDogsFemaleHeart FailureHeart RateHumansItalyMaleMembrane PotentialsAnti-Arrhythmia AgentsCatecholaminesRiluzoleRyanodine Receptor Calcium Release ChannelSodium-Calcium ExchangerSodium Channel BlockersSodium ChannelsTetrodotoxinatrial arrhythmiasatrial fibrillationcardiac arrhythmiasneuronal‐type Na+ channel blockade

Identifiers

PMID32468902
PMCPMC7429002
OpenAlexW3029930509

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.